Scott David Erickson

US Patent:

6349105, Feb 19, 2002

Filed:

May 31, 2000

Appl. No.:

09/584455

Inventors:

Patrick B. Gilliland - Chicago IL
Carlos Jines - Forest Park IL
Theodore Washburn - Barrington IL
Scott Erickson - Bartlett IL
Gregg Rapala - Arlington Heights IL

Assignee:

Stratos Lightwave, Inc. - Chicago IL

International Classification:

H01S 319

US Classification:

372 50

Abstract:

A small format optoelectronic package or device includes a non-electrically conductive substrate partially covered by an electrically conductive can. The electrically conductive can has a transparent element affixed to an aperture of the electrically conductive can. The electrically conductive can encloses and hermetically seals an optical diode, and conductors between the electrically conductive can and the non-electrically conductive substrate. The non-electrically conductive substrate has two through-holes formed through a thickness of the non-electrically conductive substrate. The two through-holes are filled with an electrically conductive material so as to form two electrically conductive vias. Additionally, a surface of the non-electrically conductive substrate is organized into two regions. The first region has the electrically conductive plating material applied thereto.

US Patent:

6425696, Jul 30, 2002

Filed:

Jun 28, 2000

Appl. No.:

09/606131

Inventors:

Bruce A. Peterson - Schaumburg IL
Theodore E. Washburn - Barrington IL
Scott Erickson - Bartlett IL
Mark C. Benton - Barrington IL

Assignee:

Stratos Lightwave - Chicago IL

International Classification:

G02B 642

US Classification:

385 92, 385 88

Abstract:

A fiber optic ferrule receptacle with a single-molded housing having a base, a cylinder on a first side of the base having a bore for receiving an optic ferrule, a socket on a second side of the base, opposing the first side, for receiving an optical element; and the bore having a first diameter at an outer opening distal to the base, and a second diameter at an inner opening adjacent to the base, wherein the first diameter is greater than the second diameter. A second embodiment comprises a single-molded housing having a base, a cylinder on a first side of the base having a bore for receiving an optic ferrule, a socket on a second side of the base, opposing the first side, for receiving an optical element; and a plurality of sloping ridges located on the inner wall of the cylinder, wherein widths of the sloping ridges increase closer to the base.

US Patent:

6735361, May 11, 2004

Filed:

Jun 1, 2001

Appl. No.:

09/860627

Inventors:

Patrick B. Gilliland - Chicago IL
Scott C. Erickson - Bartlett IL
Theodore E. Washburn - Barrington IL
Berlin Ha - Naperville IL
Sterling S. Rooke - Wheeling IL

Assignee:

Stratos Lightwave, Inc. - Chicago IL

International Classification:

G02B 634

US Classification:

385 37, 498 84, 498 85

Abstract:

A modular connector having multiple ports, comprising a housing having a first end and a second end, a first optical port on the first end, a second optical port on the first end, a third optical port on the second end, a fiber bragg grating (FBG) within the housing optically connected to the first port, said FBG configured to reflect a set wavelength back and away from the first port, a coupler within the housing optically connected to the FBG, the second port, and the third port; and wherein each of said optical ports, once connected, is capable of supporting the housing without additional support.

US Patent:

6904461, Jun 7, 2005

Filed:

Oct 19, 2000

Appl. No.:

09/692701

Inventors:

Surjit S. Randhava - Evanston IL, US
Sarabjit S. Randhava - Evanston IL, US
Sikander S. Randhava - Evanston IL, US
Scott Erickson - Evanston IL, US
Bonnie Shifrin - Chicago IL, US

Assignee:

Unitel Technologies, Inc. - Mt. Prospect IL

International Classification:

G06F015/173

US Classification:

709224, 709225

Abstract:

A method and apparatus determines an inbound traffic intensity of a visitable site, wherein the inbound traffic intensity factor is representative of a measure of meaningful visits to a visitable site in a given time period. The inbound traffic intensity factor is determined by obtaining visitor information including the number of visits to the visitable site during the given time period as well as the duration of each visit and using both the number visits and the time spent during each visit to quantify the traffic to the site during the time period.

US Patent:

7491718, Feb 17, 2009

Filed:

Oct 8, 2003

Appl. No.:

10/681784

Inventors:

Kenneth M. Comess - Winnetka IL, US
Scott A. Erickson - Zion IL, US
Jack Henkin - Highland Park IL, US
Douglas M. Kalvin - Buffalo Grove IL, US
Megumi Kawai - Libertyville IL, US
Ki H. Kim - Vista CA, US
Nwe Y. BaMaung - Niles IL, US
Chang Hoon Park - Libertyville IL, US
George S. Sheppard - Wilmette IL, US
Anil Vasudevan - Gurnee IL, US
Jieyi Wang - Lake Bluff IL, US
David M. Barnes - Lake Villa IL, US
Steve D. Fidanze - Grayslake IL, US
Lawrence Kolaczkowski - Gurnee IL, US
Robert A. Mantei - Franklin WI, US
David C. Park - Urbana IL, US
William J. Sanders - Fox Lake IL, US
Jason S. Tedrow - Evanston IL, US
Gary T. Wang - Libertyville IL, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61K 31/435
A61K 31/535
A61K 31/4965
A61K 31/415
A61K 31/40
A61K 31/425
C07D 265/30
C07D 241/04
C07D 279/12
C07D 277/02
C07D 263/02
C07C 255/03
A61K 31/42

US Classification:

5142278

Abstract:

Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.

US Patent:

7772231, Aug 10, 2010

Filed:

Dec 28, 2006

Appl. No.:

11/617398

Inventors:

George S. Sheppard - Wilmette IL, US
Gary T. Wang - Libertyville IL, US
Fabio Palazzo - Libertyville IL, US
Randy L Bell - Lindenhurst IL, US
Robert A. Mantei - Franklin WI, US
Jieyi Wang - Lake Bluff IL, US
Robert D. Hubbard - Lindenhurst IL, US
Megumi Kawai - Libertyville IL, US
Scott A. Erickson - Zion IL, US
Nwe BaMaung - Niles IL, US
Steve D. Fidanze - Grayslake IL, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

C07D 487/04
A61K 31/497
A61K 31/4985
A61K 31/519
A61K 31/5377
C07D 413/08
A61P 35/00

US Classification:

5142342, 51425216, 51425211, 5142621, 544118, 544262

Abstract:

Compounds of formula (25) that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.

US Patent:

8067409, Nov 29, 2011

Filed:

Nov 20, 2008

Appl. No.:

12/274834

Inventors:

Nwe Y. Ba-Maung - Niles IL, US
Randy L. Bell - Lindenhurst IL, US
Richard F. Clark - Gurnee IL, US
Scott A. Erickson - Zion IL, US
Steve D. Fidanze - Grayslake IL, US
Robert D. Hubbard - Lindenhurst IL, US
Robert A. Mantei - Franklin WI, US
George S. Sheppard - Wilmette IL, US
Bryan K. Sorensen - Antioch IL, US
Gary T. Wang - Libertyville IL, US
Jieyi Wang - Lake Bluff IL, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

C07D 513/04
A61K 31/425

US Classification:

5142285, 5142358, 51425214, 51425219, 514275, 544 582, 544 60, 544 61, 544122, 544295, 544331

Abstract:

Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.

US Patent:

8354422, Jan 15, 2013

Filed:

May 26, 2010

Appl. No.:

12/788008

Inventors:

Richard F. Clark - Gurnee IL, US
Randy L. Bell - Lindenhurst IL, US
Nwe Y. Ba-maung - Niles IL, US
Scott A. Erickson - Zion IL, US
Steve D. Fidanze - Grayslake IL, US
Robert A. Mantei - Franklin WI, US
George S. Sheppard - Wilmette IL, US
Bryan K. Sorensen - Antioch IL, US
Gary T. Wang - Libertyville IL, US
Jieyi Wang - Lake Bluff IL, US

Assignee:

Abbott Laboratories Inc. - Abbott Park IL

International Classification:

C07D 403/14
C07D 413/14
A61K 31/5377
A61K 31/506

US Classification:

514275, 514248, 544235, 544333

Abstract:

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof,.